
Astraea
AI Operating System for Clinical Development
About
Astraea automates clinical trial biometrics from raw study inputs to FDA-ready outputs. The platform handles data normalization, CDISC mapping, SDTM, ADaM, TFLs, QC, and revision workflows in one auditable system, helping Phase II/III sponsors reduce months of manual programming and data management into automated, reviewable execution.
Topics
- Location
- San Francisco, CA, United States
- Team size
- 6 employees
- YC batch
- Spring 2026
- Status
- Active
- Stage
- Early stage





